Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 4/20 | 0.49 |
| ▸ | TLR8 | Q9NR97 | 7/20 | 0.45 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.45 |
| ▸ | HEXA | P06865 | 5/20 | 0.44 |
| ▸ | HEXB | P07686 | 5/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | GCGR | P47871 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17545030 | 0.91 | DHFR (0.54) | DHFRTLR8TLR7HEXAHEXB | |
| SCHEMBL1091936 | 0.85 | DHFR (0.47) | DHFRTLR8TLR7HEXAHEXB | |
| SCHEMBL468531 | 0.84 | CYP2D6 (0.53) | DHFRTLR8TLR7CYP2D6 | |
| SCHEMBL11780808 | 0.82 | DHFR (0.43) | DHFRTLR8TLR7HEXAHEXB | |
| SCHEMBL9499496 | 0.81 | TLR8 (0.60) | DHFRTLR8TLR7CYP2D6 | |
| SCHEMBL29262764 | 0.80 | CYP2D6 (0.52) | DHFRTLR8TLR7CYP2D6 | |
| SCHEMBL12484463 | 0.80 | HEXA (0.48) | DHFRHEXAHEXBCYP2D6 | |
| SCHEMBL4992343 | 0.80 | TLR8 (0.40) | DHFRTLR8TLR7GCGR | |
| SCHEMBL8708770 | 0.80 | DHFR (0.41) | DHFRTLR8TLR7HEXAHEXB | |
| SCHEMBL8902382 | 0.77 | HEXA (0.43) | DHFRHEXAHEXBCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9000003-B2 | Anti-folate antimalarials with dual-binding modes and their preparation | NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY (TH) | 2015-04-07 | — | — | US | disclosed |
| US-20130324727-A1 | ANTI-FOLATE ANTIMALARIALS WITH DUAL-BINDING MODES AND THEIR PREPARATION | National Science and Techology Development Agency (TH) | 2013-12-05 | — | — | US | disclosed |
| WO-2012121682-A2 | ANTI-FOLATE ANTIMALARIALS WITH DUAL-BINDING MODES AND THEIR PREPARATION | NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY (TH) | 2012-09-13 | — | — | WO | disclosed |
| US-20090105327-A1 | Dibenzocycloheptane compounds and pharmaceuticals containing these compounds | MERCKLE GMBH (DE) | 2009-04-23 | — | — | US | disclosed |
| CN-101223153-A | Dibenzocycloheptane compounds and pharmaceuticals containingthese compounds | MERCKLE GMBH (DE) | 2008-07-16 | — | — | CN | disclosed |
| EP-1881968-A2 | DIBENZOCYCLOHEPTANE COMPOUNDS AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS | MERCKLE GMBH (DE) | 2008-01-30 | — | — | EP | disclosed |
| WO-2006120010-A2 | DIBENZOCYCLOHEPTANE COMPOUNDS AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS | MERCKLE GMBH (DE) | 2006-11-16 | — | — | WO | disclosed |
| US-20060142315-A1 | Substituted biaryl piperazinyl-pyridine analogues | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2006-06-29 | — | — | US | disclosed |
| WO-2004082613-A2 | 2,4-DIAMINO-5-[5’-SUBSTITUTED-BENZYL] PYRIMIDINES AND 2,4-DIAMINO-6-[5’-SUBSTITUTED-BENZYL] QUINAZOLINES | DANA FARBER CANCER INSTITUTE (US) | 2004-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130324727-A1 | ANTI-FOLATE ANTIMALARIALS WITH DUAL-BINDING MODES AND THEIR PREPARATION | DHFR, CYP2S1, FOLR1 | DHFR 1/4885TLR8 4290/4885TLR7 4537/4885 |
| US-20090105327-A1 | Dibenzocycloheptane compounds and pharmaceuticals containing these compounds | BDKRB1, IL1R1, IL1A | DHFR 492/4885TLR8 443/4885TLR7 186/4885 |
| US-20060142315-A1 | Substituted biaryl piperazinyl-pyridine analogues | DHFR, DPYD, DLD | DHFR 1/4885TLR8 4148/4885TLR7 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.